ITGAM and colon carcinoma: These results were consistent with the ability of CD5-2 to inhibit neutrophil migration into inflamed tissue in the MC38 colon carcinoma, in which CD5-2 inhibited the number of CD11b+/granulocyte (Gr)1hi in the solid tumor tissue.